An evidence-based review of poorly differentiated thyroid cancer

World Journal of Surgery

Volumn 31, Issue 5, 2007, Pages 934-945

  Sanders Jr , Enoch M ^a,b   LiVolsi, Virginia A ^c   Brierley, James ^d   Shin, Jennifer ^a,b   Randolph, Gregory W ^a,b,e  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CELL TYPE; EVIDENCE BASED PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PAPILLARY CARCINOMA; PROGNOSIS; SOLID TUMOR; THYROID CANCER; TUMOR DIFFERENTIATION;

EVIDENCE-BASED MEDICINE; HUMANS; PROGNOSIS; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 34248232601     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9033-3     Document Type: Article

References (57)

1. Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902-1908
2. Akslen LA, LiVolsi VA (2000) Poorly differentiated thyroid carcinoma - it is important. Am J Surg Pathol 24:310-313
3. Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a highrisk group of papillary and follicular carcinomas. Cancer 52:1849-1855
4. Nishida T, Katayama S, Tsujimoto M, et al. (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205-211
5. Sakamoto A (2004) Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 15:307-311
6. Collini P, Mattavelli F, Pellegrinelli A, et al. (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behaviour and prognosis. Am J Surg Pathol 30:1420-1426
7. Rosai J, Carcangiu ML, DeLellis RD (1992) Tumors of the Thyroid Gland. AFIP fascicle series 3, no.4. Armed Forces Institute of Pathology, Washington, DC
8. Sobrinho-Simoes M, Nesland JM, Johannessen JV (1988) Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 89:264-267
9. Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated ("insular") thyroid carcinoma. Am J Surg Pathol 8:655-668
10. Guiter GE, Auger M Ali SZ, et al. (1999) Cytopathology of insular carcinoma of the thyroid. Cancer 87:196-202
11. Leong JL, Yuen HW, LiVolsi VA, et al. (2004) Insular carcinoma of the thyroid with jugular vein invasion. Head Neck 26:642-646
12. Nikiforov YE, Gnepp DR (1994) Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer 74:748-766
13. Tronko MD, Bogdanova TI, Komissarenko IV, et al. (1999) Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics. Cancer 86:149-156
14. Harach R, Williams ED (1995) Childhood thyroid cancer in England and Wales. Br J Cancer 72:777-783
15. Williams ED, Abrosimov A, Bogdanova T, et al. (2004) Thyroid carcinoma after Chernobyl: latent period, morphology and aggressiveness. Br J Cancer 90:2219-2224
16. Nikiforov YE, Erickson LE, Nikiforova MN, et al. (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathological characteristics, molecular analysis, and biological behavior. Am J Surg Pathol 25:1478-1484
17. Volante M, Collini P, Nikiforov, Y, et al. (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol in press
18. Papotti M, Botto Micca F, Favero A, et al. (1993) Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291-301
19. Pilotti S, Collini P, Manzari A, et al. (1995) Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 12:249-255
20. Pilotti S, Collini P, Mariani L, et al. (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21:1466-1473
21. Sobrinho-Simoes M, Sambade C, Fonseca E, et al. (2002) Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol 10:123-131
22. Volante M, Landolfi S, Chiusa L, et al. (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular and solid patterns. A clinico-pathological study of 183 cases. Cancer 100:950-957
23. Volante M, Cavallo GP, Papotti M (2004) Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr Pathol 15:313-317
24. Hiltzik D, Carlson DL, Tuttle RM, et al. (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106:1286-1295
25. Ljungberg O, Bondeson L, Bondeson AG (1984) Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol 15:218-228
26. Soares P, Trovisco V, Rocha AS, et al. (2004) BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 444:572-576
27. Hosel SA, Apel RL, Freeman J, et al. (1997) Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior. Endocr Pathol 8:21-28
28. Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319-327
29. Nikiforova MN, Kimura ET, Gandhi M, et al. (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-404
30. Santoro M, Papotti M, Chiappetta G, et al. (2002) RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 87:370-379
31. Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S-4S
32. Wreesman V, Ghossein R (2002) Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549-1556
33. Luna-Ortiz K, Hurtado-López LM, Domínguez-Malagón H, et al. (2004) Clinical course of insular thyroid carcinoma. Med Sci Monit 10:cr108-111
34. Brierley J, Tsang R, Panzarella T, et al. (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63:418-427
35. Vassilopoulou-Sellin R, Schultz PN, Haynie TP (1996) Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 78:493-501
36. Pellegriti G, Giuffrida D, Scollo C, et al. (2002) Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 95:2076-2085
37. Tsang RW, Brierley JD, Simpson WJ, et al. (1998) The effects of surgery, radioiodine and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer. Cancer 82:375-388
38. Chow S-M, Law SCK, Mendenhall WM, et al. (2002) Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Physics 52:784-795
39. Esik O, Nemeth G, Eller J (1994) Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period. Oncology 51:372-379
40. Ford D, Giridharan S, McConkey C, et al. (2003) External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 15:337-341
41. Kim TH, Yang DS, Jung KY, et al. (2003) Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys 55:1006-1012
42. Phlips P, Hanzen C, Andry G, et al. (1993) Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19:399-404
43. Tubiana M, Haddad E, Schlumberger M, et al. (1985) External radiotherapy in thyroid cancers. Cancer 55:2062-2071
44. Farahati J, Reiners C, Stuschke M, et al. (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77:172-180
45. Chao TC, Lin JD, Chen MF (2004) Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg 28:393-396
46. Glanzmann C, Lutolf UM (1992) Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Strahlenther Onkol 168:260-269
47. O'Connell M, RP AH, Harmer CL (1994) Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 30A:733-739
48. Harmer C, Bidmead M, Shepherd S, et al. (1998) Radiotherapy planning techniques for thyroid cancer. Br J Radiol 71:1069-1075
49. Nutting CM, Convery DJ, Cosgrove VP, et al. (2001) Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173-180
50. Rosenbluth BD, Serrano V, Happersett L, et al. (2005) Intensitymodulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 63:1419-1426
51. Auersperg M, Us-Krasovec M, Petric G, et al. (1990) Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma. Wien Klin Wochenschr 27:267-270
52. Justin EP, Seabold JE, Robinson RA, et al. (1991) Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med 32:1358-1363
53. Lai HW, Lee CH, Chen JY, et al. (2006) Insular thyroid carcinoma: collective analysis of clinicohistologic prognostic factors and treatment effect with radioiodine or radiation therapy. J Am Coll Surg 203:715-722
54. Randolph GW, Kamani D (2006) The importance of preoperative laryngoscopy in patients undergoing thyroidectomy. Surgery 139:317
55. McCaffrey TV, Burgstrahl EJ, Hay ID, et al. (1994) Locally invasive papillary carcinoma 1940-1990. Head Neck 16:165
56. McConahey WM Hay ID, Woolner LB, et al. (1986) Papillary thyroid cancer treated at the Mayo Clinic 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clinic Proc 61:978
57. Tollefson H, DeCosse J, Hutter R (1964) Papillary carcinoma of the thyroid: a clinical and pathological study of 70 fatal cases. Cancer 17:1035